A scientific statement has been published by the AHA regarding the relationship between alcohol use and cardiovascular disease.

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Acute flares in patients with RA were linked to higher risk for AD/ADRD, but the relationship was not significant.

A large percentage of patients with SSc screened positive for ARFID, reporting significant GI symptom burden and reduced HRQOL.